From: Etiological profile of peripheral neuropathies in an academic hospital in southern Morocco
Our cohort (n = 180) | Egypt [9] (n = 1343) | Norway [12] (n = 226) | Netherlands [5] (n = 743) | Meta-analysis [8] (n = 2613) | |
---|---|---|---|---|---|
Diabetes | 26.7% | 20.40% | 18% | 32% | 34% |
Inflammatory | 27.2% | 0.74% | 16%a | 9%c | 13%c |
APRN | 26.1% | 0.37% | 12% | – | – |
CPRN | 1.1% | 0.37% | 4% | – | – |
ALS | 16.1% | – | – | – | – |
Immunological disease | 5.6% | – | 4% | 5% | 4% |
Idiopathic | 5% | 2.90% | 28% | 26% | 23% |
Medication | 5%f | – | – | – | – |
Infectious | 3.9% | 0.74% | 2% | – | – |
Hereditary | – | 0.37%b | 14%b | 5% | 6% |
Friedreich’s disease | 2.8% | 0.22% | – | – | – |
Alcohol | 2.2% | – | 10% | – | – |
Paraneoplastic | 1.7% | 0.07% | 3% | – | – |
Critical illness polyneuropathy | 1.7% | – | – | – | – |
Deficiency neuropathy | 1.1% | – | 4% | 4% | 3% |
Amyloid | 0.6% | – | – | – | – |
Toxic | 0.6% | – | – | 14%d | 13%d |
Metabolic | – | 21.89%e | – | 4%e | 4%e |
Hypoythroidism | – | 0.37% | 4% | – | – |
Liver disease | – | 0.45% | 1% | – | – |